![Patrick Lu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Lu
Gründer bei
Guangzhou Natai Biomedical Technology Co., Ltd.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Yang Lu is the founder of Sirnaomics, Inc. (founded in 2007), Intradigm Corp.
(founded in 2001), Guangzhou Natai Biomedical Technology Co., Ltd. (founded in 2012), and Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. (founded in 2008).
Titles held included Executive Vice President at Intradigm Corp.
from 2001 to 2007, Chairman at Guangzhou Natai Biomedical Technology Co., Ltd., and Chairman, President & Chief Executive Officer at Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Education history includes undergraduate (1982), graduate (1984), and doctorate (1987) degrees from Sun Yat-Sen University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SIRNAOMICS LTD. 3,19 % | 05.12.2025 | 3.499.232 ( 3,19 % ) | 3 Mio $ | 31.05.2026 |
Aktive Positionen von Patrick Lu
| Unternehmen | Position | Beginn |
|---|---|---|
Guangzhou Natai Biomedical Technology Co., Ltd.
 Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Manufactures biomedical products | Gründer | 08.05.2012 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops nucleic acid drugs | Vorstandsvorsitzender | 10.03.2008 |
Ehemalige bekannte Positionen von Patrick Lu
| Unternehmen | Position | Ende |
|---|---|---|
| SIRNAOMICS LTD. | Vorstandsvorsitzender | 06.11.2024 |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Gründer | 01.01.2007 |
Sirnaomics, Inc.
 Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel targeted therapeutics for critical human diseases | Gründer | - |
Ausbildung von Patrick Lu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Health Technology |
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel targeted therapeutics for critical human diseases | Health Technology |
Guangzhou Natai Biomedical Technology Co., Ltd.
Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops nucleic acid drugs | Health Technology |
Sirnaomics Ltd.
 Sirnaomics Ltd. BiotechnologyHealth Technology Develops therapeutics for treatment of cancer and fibrosis diseases | Health Technology |
